Kathryn Logronio

Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Shihao Chen, Li‐Fen Lee, Timothy S. Fisher et al. · Cancer Immunology Research · 2014 · 270 citations · Full text

Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function

Li‐Fen Lee, Kathryn Logronio, Guang Huan Tu et al. · Proceedings of the National Academy of Sciences · 2012 · 133 citations · Full text

Adaptive Immune System, Anti–il-7 Receptor-α Reverses, T-regulatory Cell +27

IL-7 Promotes T _H 1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis

Li‐Fen Lee, Robert C. Axtell, Guang Huan Tu et al. · Science Translational Medicine · 2011 · 112 citations

COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade

Kyle Hansen, Sandeep Kumar, Kathryn Logronio et al. · Cancer Immunology Immunotherapy · 2021 · 37 citations · Full text

Cancer Immunosurveillance, Pd-1 Pathway Blockade, Immunology +5

Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow

Gabriel J. Tsao, Jessica A. Allen, Kathryn Logronio et al. · Proceedings of the National Academy of Sciences · 2009 · 20 citations · Full text

Cell Therapy, Immunology, T Cells +16